Elsevier

Metabolism

Volume 55, Issue 1, January 2006, Pages 108-112
Metabolism

Cockcroft-Gault formula is biased by body weight in diabetic patients with renal impairment

https://doi.org/10.1016/j.metabol.2005.07.014Get rights and content

Abstract

The Cockcroft-Gault (CG) formula and the modification of diet in renal disease (MDRD) equation are commonly used to estimate glomerular filtration rate (GFR), but their validity at extreme body weight is questionable. This may be significant for diabetic patients. In 122 diabetic patients with renal damage, we compared both estimates to isotopically determined GFR by correlation studies and a Bland and Altman procedure before and after categorizing the patients according to body mass index (BMI). Over the whole population, the CG overestimated GFR (CG, 51.4 ± 23.1 mL/[min · 1.73 m2]; isotopic GFR, 44.6 ± 21.1 mL/[min · 1.73 m2], P < .0001). The MDRD (45.2 ± 17.9; NS vs isotopic GFR) did not overestimate GFR, but it underestimated high GFR as revealed by the Bland and Altman procedure (r = −0.26, P < .005). The CG underestimated GFR in patients with normal BMI (−14%, P < .01) and overestimated it in overweight (15%, P < .005) and obese patients (55%, P < .0001); the result and the error of the estimation were correlated with BMI. This bias did not affect the MDRD. The use of ideal instead of measured body weight improved the CG prediction, but underestimated GFR. As the BMI of the 87 type 2 diabetic subjects was higher, the CG overestimated their mean GFR by 18% (P < .001), whereas the MDRD did not. There were 25% fewer patients with delayed referral using the MDRD than with the CG. Because the estimate of GFR by the CG is proportional to body weight, it is not suited for obese diabetic patients. Although it is less easy to calculate, the MDRD is not affected by weight, and its use would avoid delay in referral to nephrologists.

Introduction

The evaluation of renal function is crucial in patients with chronic kidney disease [1]. Glomerular filtration rate (GFR) is traditionally considered the best overall index of renal function in health and disease [2]. According to recent guidelines [3], [4], the determination of GFR allows the diagnosis and the stratification of chronic renal failure (CRF), which has practical implications. Complications should be evaluated and treated in patients with moderate renal failure (GFR <60 mL/[min · 1.73 m2]), whereas patients with severe renal failure (GFR <30 mL/[min · 1.73 m2]) must be referred to a nephrologist with a view to dialysis. Delayed referral and treatment are associated with poor prognosis [5].

Serum creatinine concentration is widely used as an indirect marker of GFR, but it is influenced by muscle mass and diet [6]. It should not be used as the sole index of kidney function [3]. GFR can be directly measured by infusion of external substances such as inulin or 51Cr-EDTA [7], but these methods are expensive and time consuming. The use of prediction equations to estimate GFR from serum creatinine and other variables (age, sex, race, and body size) is therefore recommended by the National Kidney Foundation [3]. The proposed equations are the Cockcroft-Gault (CG) formula [8] and the modification of diet in renal disease (MDRD) study equation [2]. However, these equations have not been validated in conditions of extreme body size or severe malnutrition. Their predictive values have not been compared, and GFR may need to be measured directly in such cases [3].

Diabetes is the leading cause of end-stage renal disease in the Western world [9]. Mainly because of the high prevalence and better life expectancy of type 2 diabetic patients [10], the proportion of patients with both diabetes and end-stage renal disease is rising dramatically in developed countries [11]. The use of the CG formula to assess renal function is recommended by the American Diabetes Association [12], but this equation includes weight, which varies widely among diabetic patients; both obesity and malnutrition are more frequent in hemodialyzed diabetic patients [13]. The more recent MDRD equation does not include body weight, but it has not been validated in diabetic kidney disease [2]. Its superiority over the CG has been mentioned in some [14], but not all [15], recent reports. None of these studies included diabetic patients with kidney damage.

In 122 diabetic patients with kidney damage, we compared CG- and MDRD-estimated GFR to values measured by a reference method (51Cr-EDTA). We studied the correlation between both estimates and isotopic measurement of GFR, and we performed a Bland and Altman procedure [16]. To determine the influence of body weight on the estimations, we repeated the comparison and the correlation studies after the patients were categorized as normal (body mass index [BMI] <25 kg/m2), overweight (BMI ≥25 to <30 kg/m2), or obese (BMI ≥30 kg/m2), and we calculated the CG based on the ideal body weight of the subjects (as defined by body weight for BMI = 22 kg/m2). Comparisons and correlations were also studied separately in types 1 and 2 diabetic patients.

Section snippets

Patients

One hundred twenty-two adult diabetic patients attending our clinical unit were studied. The patients were included if they were renal insufficient, indicated by an isotopic GFR below 60 mL/(min · 1.73 m2) (n = 87) or if they had at least some kidney damage as defined by an isotopic GFR below 90 mL/(min · 1.73 m2) and microalbuminuria of more than 30 mg/24 hours (n = 35). Patients with nephrotic proteinuria (>3 g/24 hours) or anasarca were excluded. No patient was treated by dialysis at the

Results

Both sexes (67 men, 55 women) and types of diabetes (35 type 1, 87 type 2) were represented. Mean hemoglobin A1c was 8.4% ± 1.6%. A wide range of age (30-83 years; mean ± SD, 65.6 ± 11.3 years), BMI (15.6-48.9 kg/m2; mean ± SD, 27.5 ± 4.8 kg/m2), and serum creatinine levels (67-371 μmol/L; mean ± SD, 152 ± 71 μmol/L) were represented. Mean proteinuria was 626 ± 947 mg/24 hours.

Mean isotopic GFR was 44.6 ± 21.1 mL/(min · 1.73 m2). Mean CG overestimated GFR (51.4 ± 23.1 mL/[min · 1.73 m2], P <

Discussion

Our comparison between the CG and MDRD estimations of GFR in diabetic patients with renal impairment is clearly in favor of the MDRD formula. The mean MDRD estimates were close to isotopically measured GFR, with higher correlation coefficients, and no bias because of BMI. These results are in line with those of the original MDRD study [2] and the more recent report from Hallan et al [14]. These studies however included a marginal proportion of diabetic patients (6% in the MDRD, not reported in

Acknowledgment

We thank Dr S Jarman for revision of the English manuscript.

References (27)

  • Agence Nationale d'Accréditation et d'Evaluation en Santé

    Diagnostic de l'insuffisance rénale chronique chez l'adulte

    Diabetes Metab

    (2003)
  • B.J. Barret et al.

    Prediction of early death in end-stage renal disease patients starting dialysis

    Am J Kidney Dis

    (1997)
  • A.S. Levey et al.

    Serum creatinine and renal function

    Annu Rev Med

    (1988)
  • Cited by (0)

    View full text